Middleton & Co’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$337K Hold
1,150
0.04% 132
2025
Q4
$403K Sell
1,150
-375
-25% -$127K 0.04% 125
2025
Q3
$493K Hold
1,525
0.05% 115
2025
Q2
$593K Hold
1,525
0.07% 109
2025
Q1
$663K Hold
1,525
0.08% 104
2024
Q4
$563K Hold
1,525
0.06% 106
2024
Q3
$793K Hold
1,525
0.09% 102
2024
Q2
$826K Hold
1,525
0.1% 95
2024
Q1
$791K Hold
1,525
0.09% 101
2023
Q4
$719K Hold
1,525
0.09% 99
2023
Q3
$664K Sell
1,525
-50
-3% -$22.7K 0.09% 95
2023
Q2
$700K Sell
1,575
-125
-7% -$57.7K 0.09% 95
2023
Q1
$782K Hold
1,700
0.11% 93
2022
Q4
$872K Buy
1,700
+500
+42% +$254K 0.13% 96
2022
Q3
$545K Hold
1,200
0.08% 104
2022
Q2
$579K Sell
1,200
-134
-10% -$66.3K 0.07% 106
2022
Q1
$655K Sell
1,334
-66
-5% -$30.2K 0.07% 111
2021
Q4
$649K Hold
1,400
0.06% 112
2021
Q3
$522K Hold
1,400
0.06% 118
2021
Q2
$535K Buy
1,400
+200
+17% +$76.4K 0.06% 114
2021
Q1
$431K Hold
1,200
0.05% 117
2020
Q4
$385K Hold
1,200
0.05% 120
2020
Q3
$322K Hold
1,200
0.04% 119
2020
Q2
$316K Hold
1,200
0.05% 126
2020
Q1
$272K Buy
+1,200
New +$327K 0.05% 127

Other funds holding ELV

Middleton & Co's ELV Position: Q1 2026 in Review

Middleton & Co held its Elevance Health (ELV) position steady in Q1 2026 at 1,150 shares worth $337K. The position accounts for 0.04% of the portfolio, ranked #132.

Middleton & Co first reported a position in ELV in Q1 2020 and has held it in 25 quarters since. The position peaked at $872K in Q4 2022. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Middleton & Co held 1,150 shares of Elevance Health worth $337K as of Q1 2026.
  • Middleton & Co left its Elevance Health share count unchanged in Q1 2026.
  • Elevance Health made up 0.04% of Middleton & Co's portfolio in Q1 2026, its #132 holding.
  • Middleton & Co first reported a position in Elevance Health in Q1 2020 and has held it in 25 quarters since.
  • Middleton & Co's Elevance Health position peaked at $872K in Q4 2022.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Middleton & Co's 13F filing for Q1 2026, filed 8 May 2026.